leadf
logo-loader
viewCalyxt

Calyxt licenses new, unique technology that aims to bring plant products to market quickly

Calyxt Inc (NASDAQ:CLXT) CEO Jim Blome tells Proactive the Roseville, Minnesota-based company has licensed a new, unique technology designed to boost efficiency in gene-edited plants.

Blome explains how the method, developed by the University of Minnesota, potentially reduces the time needed to edit plants to a matter of months rather than years, and how it fits in with its existing technology named TALEN.

Quick facts: Calyxt

Price: 3.55 USD

NASDAQ:CLXT
Market: NASDAQ
Market Cap: $131.58 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Calyxt named herein, including the promotion by the Company of Calyxt in any Content on the Site, the Company receives from said issuer annual...

FOR OUR FULL DISCLAIMER CLICK HERE

Curtis Banks' transition to a more sustainable, resilient business model

Curtis Banks Group Will Self talks to Proactive London's Katie Pilbeam about their trading and operations update. He says they have continued to invest in the business committing £5m to investment in technology, over a 5 year period. The company has already delivered a new online portal,...

17 hours, 10 minutes ago

2 min read